Sudarshan Pharma Industries Limited (SPIL), a Mumbai-based company founded in 2008, has a contract manufacturing facility to find and provide generic formulations. Additionally, it supplies specialized chemicals, APIs (Active Pharmaceutical Ingredients), and intermediates in addition to engaging in import and export operations. They contract with suppliers in India and other countries to manufacture products based on the specifications and demands of their customers.
The company’s generic goods are widely used in the adhesive, food, paint, and pharmaceutical industries. Hospitals, non-profit organizations, the government, and healthcare institutions can purchase drugs and pharmaceutical formulations from the corporation, which also provides these services. There are 50 pharmaceutical formulations produced by SPIL that are sold under the brand name and are available as tablets, ointments, capsules, and injectables.
Sudarshan Pharma IPO Details
| IPO Date | Jun 12, 2019 to Jun 21, 2019 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹72 per share |
| Lot Size | 1600 Shares |
| Issue Size | 3,440,000 shares of ₹10 (aggregating up to ₹24.77 Cr) |
| Market Maker portion | 176,000 shares |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Mr. Hemal V. Mehta and Mr. Sachin V. Mehta are the promoters of the company. |
Sudarshan Pharma IPO Tentative Dates
Sudarshan Pharma IPO opens on Jun 12, 2019, and closes on Jun 21, 2019. The Sudarshan Pharma IPO bid date is from Jun 12, 2019 10.00 A.M. to Jun 21, 2019 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.
| Event | Tentative Date |
|---|---|
| Opening Date | Jun 12, 2019 |
| Closing Date | Jun 21, 2019 |
| Basis of Allotment | Jun 20, 2019 |
| Initiation of Refunds | Jun 21, 2019 |
| Credit of Shares to Demat | Jun 24, 2019 |
| Listing Date | Jun 25, 2019 |
Company Financials
| Particulars | For the year/period ended (in Rs. Lakhs) | |||
|---|---|---|---|---|
| 31-Mar-19 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |
| Total Assets | 5,013.72 | 3,096.37 | 1,992.93 | 827.24 |
| Total Revenue | 14,001.96 | 8,976.43 | 5,551.72 | 3,794.33 |
| Profit After Tax | 234.79 | 73.98 | 15.63 | 9.27 |
Objects of the Issue
The following goals are proposed for the Company to pursue with the Net Funds from the Issue:
1) To establish a dedicated production facility for the pharmaceutical industry
2) To purchase a corporate office and distribution and warehousing centres
3) To cover the costs of the Offering, additional working capital, general corporate expenses, and further working capital.
Sudarshan Pharma IPO Prospectus
Company Contact Information
Sudarshan Pharma Industries Limited
301, 3rd Floor, Aura Biplex,
Above Kalyan Jewellers, S V Road,
Borivali (West), Mumbai – 400 092,
Phone: +91 22 242221111
Email: compliance.spil@gmail.com
Website: http://www.sudarshanpharma.com/
Sudarshan Pharma IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://karisma.kfintech.com/
Sudarshan Pharma IPO Lead Manager(s)
- First Overseas Capital Limited (Past IPO Performance)
, a Mumbai-based company founded in 2008, has a contract manufacturing facility to find and provide){kind=link}